Live Webinar 2: Therapy by Design: How Genetics Shape Treatment Decisions (2025)
This webinar is scheduled for Wednesday, June 18, 2025 at 2:00 PM ET.
Keri Miller will provide an in-depth exploration of genetic cancer genes, focusing on their role in cancer diagnosis and management. A detailed analysis of the Oncotype DX test will be presented, including an explanation of how it works, what it measures, and its significance in guiding treatment decisions for breast cancer patients.
Learning Objectives:
- Review the significance of understanding genetic cancer genes for targeted therapy.
- Outline how Oncotype DX influences treatment decisions, particularly in hormone receptor-positive, HER2-negative breast cancer, and how it can reduce overtreatment and personalize therapy.
- Discuss the determinants of clinical decision making based on inherited genetic variations.
Next Steps After Purchase:
The activity will automatically load into the My Learning Activities page under LIVE Webinars. The quiz will become available after the live broadcast. Make sure to complete the quiz, evaluation and claim CE credit at that time. The enrollment period for this activity is 90 days after the date of the live broadcast.
Three to four days prior to the live presentation, you will receive an email with instructions and a link explaining how to register with GoToWebinar. This will provide you access to the presentation on the scheduled date. If you do not receive the email by 12:00 PM ET on the scheduled date of the webinar, please contact education@ncra-usa.org.